Menu
Back to Journals » ImmunoTargets and Therapy
ESCI
ImmunoTargets and Therapy
ISSN: 2253-1556
Editor-in-Chief: Dr Michael R Shurin
An international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Indexed online:
- Emerging Sources Citation Index (ESCI), from 2016
- PubMed and PubMed Central (Immunotargets Ther)
- Embase, from 2015 (Correct as at December 8, 2016)
- Directory of Open Access Journals (DOAJ)
- OAIster: The Open Access initiative
Related journals you may also be interested in:
- Adolescent Health, Medicine and Therapeutics
- Biologics: Targets and Therapy
- Clinical Interventions in Aging
- Clinical Pharmacology: Advances and Applications
- ClinicoEconomics and Outcomes Research
- Core Evidence
- Drug Design, Development and Therapy
- Drug, Healthcare and Patient Safety
- Integrated Pharmacy Research and Practice
- International Journal of Nanomedicine
- Journal of Experimental Pharmacology
- Journal of Receptor, Ligand and Channel Research
- Open Access Journal of Clinical Trials
- Patient Preference and Adherence
- Pharmacogenomics and Personalized Medicine
- Therapeutics and Clinical Risk Management